Progress in the treatment of diabetic cardiomyopathy, a systematic review
Abstract Diabetic cardiomyopathy (DCM) is a condition characterized by myocardial dysfunction that occurs in individuals with diabetes, in the absence of coronary artery disease, valve disease, and other conventional cardiovascular risk factors such as hypertension and dyslipidemia. It is considered...
Saved in:
Main Authors: | Yiyi Shou (Author), Xingyu Li (Author), Quan Fang (Author), Aqiong Xie (Author), Yinghong Zhang (Author), Xinyan Fu (Author), Mingwei Wang (Author), Wenyan Gong (Author), Xingwei Zhang (Author), Dong Yang (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exogenous Pancreatic Kallikrein Improves Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetes
by: Meng Wu, et al.
Published: (2018) -
Beneficial Effects of Echinacoside on Diabetic Cardiomyopathy in Diabetic Db/Db Mice
by: Zhang X, et al.
Published: (2020) -
Combination of ADAM17 knockdown with eplerenone is more effective than single therapy in ameliorating diabetic cardiomyopathy
by: Lin Xie, et al.
Published: (2024) -
Epicardial Adipose Tissue and Diabetic Cardiomyopathy
by: Xueyuan Yang MM, et al.
Published: (2023) -
A risk model developed based on necroptosis to assess progression for ischemic cardiomyopathy and identify possible therapeutic drugs
by: Yang Lu, et al.
Published: (2022)